- Home
- PYPD vs ATER Comparison
PYPD vs ATER Comparison
Compare PYPD & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- ATER
- Stock Information
- Founded
- PYPD 2008
- ATER 2014
- Country
- PYPD Israel
- ATER United States
- Employees
- PYPD N/A
- ATER N/A
- Industry
- PYPD Medical/Dental Instruments
- ATER Home Furnishings
- Sector
- PYPD Health Care
- ATER Consumer Discretionary
- Exchange
- PYPD Nasdaq
- ATER Nasdaq
- Market Cap
- PYPD 24.2M
- ATER 25.8M
- IPO Year
- PYPD 2020
- ATER N/A
- Fundamental
- Price
- PYPD $3.56
- ATER $2.54
- Analyst Decision
- PYPD Strong Buy
- ATER Strong Buy
- Analyst Count
- PYPD 2
- ATER 1
- Target Price
- PYPD $12.00
- ATER N/A
- AVG Volume (30 Days)
- PYPD 8.1K
- ATER 47.4K
- Earning Date
- PYPD 11-13-2024
- ATER 11-11-2024
- Dividend Yield
- PYPD N/A
- ATER N/A
- EPS Growth
- PYPD N/A
- ATER N/A
- EPS
- PYPD N/A
- ATER N/A
- Revenue
- PYPD N/A
- ATER $107,193,000.00
- Revenue This Year
- PYPD N/A
- ATER N/A
- Revenue Next Year
- PYPD N/A
- ATER $5.45
- P/E Ratio
- PYPD N/A
- ATER N/A
- Revenue Growth
- PYPD N/A
- ATER N/A
- 52 Week Low
- PYPD $2.95
- ATER $0.23
- 52 Week High
- PYPD $9.20
- ATER $3.95
- Technical
- Relative Strength Index (RSI)
- PYPD 54.93
- ATER 32.74
- Support Level
- PYPD $3.30
- ATER $2.85
- Resistance Level
- PYPD $3.59
- ATER $3.10
- Average True Range (ATR)
- PYPD 0.21
- ATER 0.19
- MACD
- PYPD 0.02
- ATER -0.02
- Stochastic Oscillator
- PYPD 68.27
- ATER 0.35
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.